Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Reviews in Allergy & Immunology
Published in: Clinical Reviews in Allergy & Immunology 1/2011

01-02-2011

Reproductive Immunology: a Focus on the Role of Female Sex Hormones and Other Gender-Related Factors

Author: Elena Peeva

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2011

Login to get access

Abstract

Reproductive immunology has attracted the attention of researchers interested in fertility and pregnancy as well as those interested in immunity and autoimmunity. Over the past couple of decades, a wealth of data on the immune-reproductive interactions has been generated. This issue of the Journal will examine several topics including the role of immune factors in the induction of anti-Ro antibody-mediated autoimmunity in neonates and the immunological effects of gender and sex hormones. The possible implications of the research reviewed here for the development of novel therapeutic approaches are also addressed.
Literature
1.
Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N et al (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8:24–28PubMedCrossRef
2.
Gomez-Martin D, Diaz-Zamudio M, Crispin J, Alcocer-Varela J (2009) Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun Rev 9:34–39PubMedCrossRef
3.
Kong Y, Jacob J, Flynn J, Elliott B, Wei W (2009) Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun Rev 9:28–33PubMedCrossRef
4.
Kabalak G, Dobberstein S, Matthias T, Reuter S, YH T, Dörner T et al (2009) Association of immunoglobulin-like transcript 6 deficiency with Sjögren's syndrome. Arthritis Rheum 60:2923–2925PubMedCrossRef
5.
Campbell I, Kinkel S, Drake S, van Nieuwenhuijze A, Hubert F, Tarlinton D et al (2009) Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 60:1683–1693PubMedCrossRef
6.
Bianco N, Kim S, Ruffner M, Robbins P (2009) Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum 60:380–389PubMedCrossRef
7.
Satpute S, Durai M, Moudgil K (2008) Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis. Semin Arthritis Rheum 38:195–207PubMedCrossRef
8.
Lambrecht B, Hammad H (2009) Biology of lung dendritic cells at the origin of asthma. Immunity 31:412–424PubMedCrossRef
9.
Khan S, Greenberg J, Bhardwaj N (2009) Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol 5:566–571PubMedCrossRef
10.
Gurung P, Kucaba T, Ferguson T, Griffith T (2009) Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. J Immunol 183:6114–6123PubMedCrossRef
11.
Vocanson M, Hennino A, Rozières A, Poyet G, Nicolas J (2009) Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64:1699–1714PubMedCrossRef
12.
Koffeman E, Genovese M, Amox D, Keogh E, Santana E, Matteson E et al (2009) Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 60:3207–3216PubMedCrossRef
13.
Sioud M (2009) Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines? Scand J Immunol 70:516–525PubMedCrossRef
14.
Pozo D, Anderson P, Gonzalez-Rey E (2009) Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. J Immunol 183:4346–4359PubMedCrossRef
15.
Wang J, Huizinga T, Toes R (2009) De novo generation and enhanced suppression of human CD4 + CD25+ regulatory T cells by retinoic acid. J Immunol 183:4119–4126PubMedCrossRef
16.
Lutz M, Kurts C (2009) Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells. Eur J Immunol 39:2325–2330PubMedCrossRef
17.
Zheng J, Liu Y, Qin G, Chan P, Mao H, Lam K et al (2009) Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 183:3742–3750PubMedCrossRef
18.
Merianos D, Tiblad E, Santore M, Todorow C, Laje P, Endo M et al (2009) Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice. J Clin Invest 119:2590–2600PubMed
19.
Gabrysová L, Nicolson K, Streeter H, Verhagen J, Sabatos-Peyton C, Morgan D et al (2009) Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 206:1755–1767PubMedCrossRef
20.
Yu P, Xiong S, He Q, Chu Y, Lu C, Ramlogan C et al (2009) Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts. Immunology 127:500–511PubMedCrossRef
21.
CZ GRM, He W, Khatri I, Sun Y, Yu K, Boudakov I (2009) Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 183:1560–1568CrossRef
22.
Hsiao H, Liu W, Wang C, Lo Y, Wu Y, Jiang S et al (2009) Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy. Immunity 31:72–83PubMedCrossRef
23.
Turka L, Lechler R (2009) Towards the identification of biomarkers of transplantation tolerance. Nat Rev Immunol 9:521–526PubMedCrossRef
24.
25.
Bournia V, Vlachoyiannopoulos P, Selmi C, Moutsopoulos H, Gershwin M (2009) Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 36:176–200PubMedCrossRef
26.
Keller A, Schildknecht A, Xiao Y, van den Broek M, Borst J (2008) Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity 29:934–946PubMedCrossRef
27.
Schartner J, Singh A, Dahlberg P, Nettenstrom L, Seroogy C (2009) Recurrent superantigen exposure in vivo leads to highly suppressive CD4 + CD25+ and CD4 + CD25− T cells with anergic and suppressive genetic signatures. Clin Exp Immunol 155:348–356PubMedCrossRef
28.
Flores-Borja F, Jury E, Mauri C, Ehrenstein M (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci USA 105:19396–19401PubMedCrossRef
29.
Min S, Park K, Cho M, Kang J, Cho Y, Hwang S et al (2006) Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum 54:887–898PubMedCrossRef
30.
Caspi R (2008) Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 8:970–976PubMedCrossRef
31.
Brusko T, Putnam A, Bluestone J (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223:371–390PubMedCrossRef
32.
Bettelli E, Korn T, Oukka M, Kuchroo V (2008) Induction and effector functions of T(H)17 cells. Nature 453:1051–1057PubMedCrossRef
33.
Chen W, Mempel M, Schober W, Behrendt H, Ring J (2008) Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 63:1418–1427PubMedCrossRef
34.
Marriott I, Huet-Hudson Y (2006) Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34:177–192PubMedCrossRef
35.
Redondo M, Fain P, Krischer J, Yu L, Cuthbertson D, Winter W et al (2004) Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. J Autoimmun 23:275–279PubMedCrossRef
36.
Roden A, Moser M, Tri S, Mercader M, Kuntz S, Dong H et al (2004) Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 173:6098–6108PubMed
37.
Mustafa A, Holladay S, Goff M, Witonsky S, Kerr R, Reilly C et al (2008) An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol 232:51–59PubMedCrossRef
38.
Hatta K, van den Heuvel M, Croy B (2009) NK cells detect changes in adaptive immunity within mouse decidua from gestation day eight. Placenta 30:501–506PubMedCrossRef
39.
Lahita R (2000) Gender and the immune system. J Gend Specif Med 3:19–22PubMed
40.
Mjösberg J, Svensson J, Johansson E, Hellström L, Casas R, Jenmalm M et al (2009) Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. J Immunol 183:759–769PubMedCrossRef
41.
Gleicher N, Weghofer A, Oktay K, Barad D (2009) Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause 16:760–764PubMedCrossRef
42.
Vargas-Villavicencio J, De León-Nava M, Morales-Montor J (2009) Immunoendocrine mechanisms associated with resistance or susceptibility to parasitic diseases during pregnancy. Neuroimmunomodulation 16:114–121PubMedCrossRef
43.
Chapman J, Min S, Freeh S, Michael S (2009) The estrogen-injected female mouse: new insight into the etiology of PCOS. Reprod Biol Endocrinol 7:47–58PubMedCrossRef
44.
Moxley G, Posthuma D, Carlson P, Estrada E, Han J, Benson L et al (2002) Sexual dimorphism in innate immunity. Arthritis Rheum 46:250–258PubMedCrossRef
45.
Hughes G, Martin D, Zhang K, Hdkins L, Alpers C, Clark A et al (2009) Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis Rheum 60:1775–1784PubMedCrossRef
46.
Wang F, Roberts S, Butfiloski E, Sobel E (2007) Diminished prolactin from chlordecone treatment in ovariectomized (NZB×NZW)F(1) mice. Int Immunopharmacol 7:1808–1812PubMedCrossRef
47.
Wang F, Sobel E, Butfiloski E, Roberts S (2008) Comparison of chlordecone and estradiol effects on splenic T-cells in (NZB×NZW)F(1) mice. Toxicol Lett 183:1–9PubMedCrossRef
48.
Polanczyk M, Hopke C, Huan J, Vandenbark A, Offner H (2005) Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 170:85–92PubMedCrossRef
49.
Lee Y, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L et al (2009) The PRL −1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum 60:1250–1254PubMedCrossRef
50.
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E (2009) Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 60:1743–1752PubMedCrossRef
51.
Szekeres-Bartho J, Halasz M, Palkovics T (2009) Progesterone in pregnancy; receptor-ligand interaction and signaling pathways. J Reprod Immunol 83:60–64PubMedCrossRef
52.
Segerer S, Müller N, van den Brandt J, Kapp M, Dietl J, Reichardt H et al (2009) Impact of female sex hormones on the maturation and function of human dendritic cells. Am J Reprod Immunol 62:165–173PubMedCrossRef
53.
Meier A, Chang J, Chan E, Pollard R, Sidhu H, Kulkarni S et al (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955–959PubMedCrossRef
54.
Butts C, Bowers E, Horn J, Shukair S, Belyavskaya E, Tonelli L et al (2008) Inhibitory effects of progesterone differ in dendritic cells from female and male rodents. Gend Med 5:434–447PubMedCrossRef
55.
Panchanathan R, Shen H, Bupp M, Gould K, Choubey D (2009) Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol 183(11):7031–7038PubMedCrossRef
56.
Walters E, Rider V, Abdou N, Greenwell C, Svojanovsky S, Smith P et al (2009) Estradiol targets T cell signaling pathways in human systemic lupus. Clin Immunol 133:428–436PubMedCrossRef
57.
Cejkova P, Fojtikova M, Cerna M (2009) Immunomodulatory role of prolactin in diabetes development. Autoimmun Rev 9:23–27PubMedCrossRef
58.
Sawalha A, Harley J, Scofield R (2009) Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 33:31–34PubMedCrossRef
59.
Scofield R (2009) Genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 21:448–453PubMedCrossRef
60.
Santiago-Raber M, Kikuchi S, Borel P, Uematsu S, Akira S, Kotzin B et al (2008) Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 181:1556–1562PubMed
61.
Zhou Y, Yuan J, Pan Y, Fei Y, Qiu X, Hu N et al (2009) T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 132:362–370PubMedCrossRef
62.
Hemminki K, Li X, Sundquist K, Sundquist J (2009) Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum 60:2845–2847PubMedCrossRef
63.
Clancy R, Buyon J, Ikeda K, Nozawa K, Argyle D, Friedman D et al (2005) Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 52:3079–3086PubMedCrossRef
64.
Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M (2002) A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 46:1233–1241PubMedCrossRef
65.
Petri M, Watson R, Hochberg M (1989) Anti-Ro antibodies and neonatal lupus. Rheum Dis Clin North Am 15:335–360PubMed
66.
St Clair E (1992) Anti-La antibodies. Rheum Dis Clin North Am 18:359–376PubMed
67.
Lazzerini P, Capecchi P, Guideri F, Acampa M, Galeazzi M, Laghi Pasini F (2006) Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev 5:306–313PubMedCrossRef
68.
Brucato A, Cimaz R, Caporali R, Ramoni R, Buyon J (2010) Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol (this issue)
69.
Ackerman L (2006) Sex hormones and the genesis of autoimmunity.Ackerman LS. Arch Dermatol 142:371–376PubMedCrossRef
70.
d'Elia H, Carlsten H (2008) The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scand J Immunol 68:661–667PubMedCrossRef
71.
Rodriguez E, Guevara J, Paez A, Zapata E, Collados M, Fortoul T et al (2008) The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens. Lupus 17:1086–1095PubMedCrossRef
72.
Joyce M, Burghardt J, Burghardt R, Hooper R, Bazer F, Johnson G (2008) Uterine MHC class I molecules and beta 2-microglobulin are regulated by progesterone and conceptus interferons during pig pregnancy. J Immunol 18:2494–2505
73.
Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L et al (2008) Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453:1117–1121PubMedCrossRef
74.
75.
Bouman A, Heineman M, Faas M (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423PubMedCrossRef
76.
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi M, Villaggio B et al (2006) Estrogens and autoimmune diseases. Ann NY Acad Sci 1089:538–547PubMedCrossRef
77.
78.
Verthelyi D, Petri M, Ylamus M, Klinman DM (2001) Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 10:352–358PubMedCrossRef
79.
Olsen N, Kovacs W (2002) Hormones, pregnancy, and rheumatoid arthritis. J Gend Specif Med 5:28–37PubMed
80.
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH (2004) Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13(9):635–638PubMedCrossRef
81.
Peeva E, Zouali M (2005) Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 101:123–143PubMedCrossRef
82.
Sanchez-Guerrero J, Karlson E, Liang M et al (1997) Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40:804–808PubMedCrossRef
83.
Sanchez-Guerrero J, Uribe A, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc A (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539–2549PubMedCrossRef
84.
Karpuzoglu E, Zouali M (2010) The multi-faceted influences of estrogen on lymphocytes: toward novel immunointerventions strategies for autoimmunity management. Clin Rev Allergy Immunol (this issue)
85.
Walker S (2010) Estrogen and autoimmune disease. Clin Rev Allergy Immunol (this issue)
86.
Cunningham M, Gilkeson G (2010) Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol (this issue)
87.
Saha S, Tieng A, Pepeljugoski K, Zandamn-Goddard G, Peeva E. (2010) Prolactin, systemic lupus erythematosus and autoreactive B cells: lessons learnt from murine models. Clin Rev Allergy Immunol (this issue)
88.
Jara L, Medina G, Saavedra M, Vera-Lastra O, Navarro C (2010) Prolactin and autoimmunity. Clin Rev Allergy Immunol (this issue)
89.
90.
91.
Doria A, Iaccarino L, Sarzi-Puttini P, Ghirardello A, Zampieri S, Arienti S et al (2006) Estrogens in pregnancy and systemic lupus erythematosus. Ann NY Acad Sci 1069:247–256PubMedCrossRef
92.
Soto M, Vallejo M, Guillén F, Simón J, Arena E, Reyes P (2004) Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol 22:713–721PubMed
93.
Weckerle C, Niewold T (2010) The unexplained female predominance of systemic lupus erythematosus: clues from human genetic and cytokine studies. Clin Rev Allergy Immunol (this issue)
94.
Bhat A, Naguwa S, Cheema G, Gershwin ME (2010) The epidemiology of transverse myelitis. Autoimmun Rev 9:A395–A399PubMedCrossRef
95.
Borchers AT, Uibo R, Gershwin ME (2010) The geoepidemiology of type 1 diabetes. Autoimmun Rev 9:A355–A365PubMedCrossRef
96.
97.
Rook GA (2010) 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Darwinian medicine and the 'hygiene' or 'old friends' hypothesis. Clin Exp Immunol 160:70–79PubMedCrossRef
98.
Deane S, Teuber SS, Gershwin ME (2010) The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 9:A342–A349PubMedCrossRef
99.
Lambert JF, Nydegger UE (2010) Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 9:A350–A354PubMedCrossRef
100.
Knip M, Virtanen SM, Akerblom HK (2010) Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr 91:1506S–1513SPubMedCrossRef
101.
Kochi Y, Suzuki A, Yamada R, Yamamoto K (2010) Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis. Nat Rev Rheumatol 6:290–295PubMedCrossRef
102.
Orozco G, Barton A (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 6:61–75PubMedCrossRef
103.
Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH (2010) Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 9:A400–A405PubMedCrossRef
104.
Logan I, Bowlus CL (2010) The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 9:A372–A378PubMedCrossRef
105.
Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S et al (2010) Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24:13–27PubMedCrossRef
106.
Wei Q, Bundell C, Wu JS, Castley A, James I, Hollingsworth P et al (2010) Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult Scler 16:351–354CrossRef
107.
Meyer A, Levy Y (2010) Chapter 33: geoepidemiology of myasthenia gravis. Autoimmun Rev 9:A383–A386PubMedCrossRef
108.
Meyer N, Misery L (2010) Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 9:A379–A382PubMedCrossRef
109.
Milo R, Kahana E (2010) Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9:A387–A394PubMedCrossRef
110.
Sands J, Tuscano JM (2010) Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 9:A335–A341PubMedCrossRef
111.
Kolfenbach JR, Deane KD, Derber LA, O'Donnell C, Weisman MH, Buckner JH et al (2009) A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum 61:1735–1742PubMedCrossRef
112.
113.
Barkoff MS, Kocherginsky M, Anselmo J, Weiss RE, Refetoff S (2010) Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 95:3189–3193PubMedCrossRef
114.
115.
Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319–A324PubMedCrossRef
116.
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P (2010) Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 9:494–498PubMedCrossRef
117.
van Melick EJ, Wilting I, Meinders AE, Egberts TC (2010) Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients. Am J Geriatr Psychiatry 18:395–403PubMedCrossRef
118.
Biggioggero M, Meroni PL (2010) The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 9:A299–A304PubMedCrossRef
119.
Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277–A287PubMedCrossRef
120.
Leite JL, Bufalo NE, Santos RB, Romaldini JH, Ward LS (2010) Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease. Eur J Endocrinol 162:315–321PubMedCrossRef
121.
Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314–J321PubMedCrossRef
122.
Chen M, Kallenberg CG (2010) The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 9:A293–A298PubMedCrossRef
123.
Pauklin S, Sernandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK (2009) Estrogen directly activates AID transcription and function. J Exp Med 206:99–111PubMedCrossRef
124.
Rojas-Villarraga A, Toro CE, Espinosa G, Rodriguez-Velosa Y, Duarte-Rey C, Mantilla RD et al (2010) Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 9:229–232PubMedCrossRef
125.
Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9:A325–A329PubMedCrossRef
126.
Kaloumenou I, Mastorakos G, Alevizaki M, Duntas LH, Mantzou E, Ladopoulos C et al (2008) Thyroid autoimmunity in schoolchildren in an area with long-standing iodine sufficiency: correlation with gender, pubertal stage, and maternal thyroid autoimmunity. Thyroid 18:747–754PubMedCrossRef
127.
Kondrashova A, Viskari H, Haapala AM, Seiskari T, Kulmala P, Ilonen J et al (2008) Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 93:729–734PubMedCrossRef
128.
Ortona E, Margutti P, Matarrese P, Franconi F, Malorni W (2008) Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 7:579–584PubMedCrossRef
129.
Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 34:J307–J313PubMedCrossRef
130.
Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity—autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266PubMedCrossRef
131.
132.
Mackay IR (2010) Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 9:A251–A258PubMedCrossRef
133.
Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 9:A305–A310PubMedCrossRef
134.
Prieto S, Grau JM (2010) The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 9:A330–A334PubMedCrossRef
135.
Cutolo M, Straub RH (2009) Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 11:218PubMedCrossRef
136.
La Marca A, Marzotti S, Brozzetti A, Stabile G, Artenisio AC, Bini V et al (2009) Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab 94:3816–3823PubMedCrossRef
137.
138.
139.
Selmi C, Tsuneyama K (2010) Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 9:A267–A270PubMedCrossRef
140.
141.
Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev 9:A288–A292PubMedCrossRef
142.
143.
Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE et al (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34:J327–J338PubMedCrossRef
144.
Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–J265PubMedCrossRef
145.
Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34:J287–J299PubMedCrossRef
146.
Maul RW, Gearhart PJ (2009) Women, autoimmunity, and cancer: a dangerous liaison between estrogen and activation-induced deaminase? J Exp Med 206:11–13PubMedCrossRef
147.
Persani L, Rossetti R, Cacciatore C, Bonomi M (2009) Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 33:35–41PubMedCrossRef
148.
Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207–J219PubMedCrossRef
149.
Chang C (2010) The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 34:J234–J246PubMedCrossRef
150.
Chang C, Gershwin ME (2010) Drugs and autoimmunity—a contemporary review and mechanistic approach. J Autoimmun 34:J266–J275PubMedCrossRef
151.
Chen M, Daha MR, Kallenberg CG (2010) The complement system in systemic autoimmune disease. J Autoimmun 34:J276–J286PubMedCrossRef
152.
Hoffmann MH, Trembleau S, Muller S, Steiner G (2010) Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 34:J178–J206PubMedCrossRef
153.
154.
Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H (2010) Light, including ultraviolet. J Autoimmun 34:J247–J257PubMedCrossRef
155.
Powell JJ, Faria N, Thomas-McKay E, Pele LC (2010) Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34:J226–J233PubMedCrossRef
156.
Round JL, O'Connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34:J220–J225PubMedCrossRef
157.
Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168–J177PubMedCrossRef
158.
Youinou P, Pers JO, Gershwin ME, Shoenfeld Y (2010) Geo-epidemiology and autoimmunity. J Autoimmun 34:J163–J167PubMedCrossRef
Metadata
Title
Reproductive Immunology: a Focus on the Role of Female Sex Hormones and Other Gender-Related Factors
Author
Elena Peeva
Publication date
01-02-2011
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2011
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-010-8209-z

Other articles of this Issue 1/2011

Clinical Reviews in Allergy & Immunology 1/2011 Go to the issue

OriginalPaper

Estrogen and Autoimmune Disease

OriginalPaper

Prolactin and Autoimmunity

ReviewPaper

Estrogen Receptors in Immunity and Autoimmunity

OriginalPaper

The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies

OriginalPaper

The Multi-faceted Influences of Estrogen on Lymphocytes: Toward Novel Immuno-interventions Strategies for Autoimmunity Management

OriginalPaper

Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits